Intracellular cGMP increase is not involved in thyroid cancer cell death

INTRODUCTION: Type 5 phosphodiesterase (PDE5) inhibitors (PDE5i) lead to intracellular cyclic-guanosine monophosphate (cGMP) increase and are used for clinical treatment of erectile dysfunction. Studies found that cGMP may up/downregulate the growth of certain endocrine tumor cells, suggesting that...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessandro, Sara D’, Paradiso, Elia, Lazzaretti, Clara, Sperduti, Samantha, Perri, Carmela, Antoniani, Francesco, Righi, Sara, Simoni, Manuela, Brigante, Giulia, Casarini, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062617/
https://www.ncbi.nlm.nih.gov/pubmed/36996255
http://dx.doi.org/10.1371/journal.pone.0283888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062617/
https://www.ncbi.nlm.nih.gov/pubmed/36996255
http://dx.doi.org/10.1371/journal.pone.0283888

Ejemplares similares